Want to see GB:FAB full AI Analyst Report?

Fusion Antibodies Plc (FAB) Revenue

10 Followers

Fusion Antibodies Plc Revenue

Fusion Antibodies Plc had a revenue of 1.27M in the quarter ending Mar 31, 2025, with 51.79%. This bring the company's revenue in the last twelve months to 2.11M, Decreased 32.21%. In the fiscal year ending Mar 31, 2025, Fusion Antibodies Plc had annual revenue of 2.11M with 7.38% growth.

Revenue (ttm)

2.11M

Revenue Growth

7.38%

P/S Ratio

6.82

Revenue/Employee

£78,148

Employees

Market Cap

£14.39M

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Mar 31, 2025	2.11M	145.00K	+7.38%
Mar 31, 2024	1.97M	829.00K	+72.98%
Mar 31, 2023	1.14M	-1.76M	-60.84%
Mar 31, 2022	2.90M	-1.90M	-39.55%
Mar 31, 2021	4.80M	634.00K	+15.22%
Mar 31, 2020	4.17M	270.00K	+6.93%
Mar 31, 2019	3.90M	1.20M	+44.76%
Mar 31, 2018	2.69M	508.91K	+23.32%
Mar 31, 2018	2.18M	―	―